Financial Market News

Nvidia fell 4.3% as AMD jumped 13.3% and most chip stocks rallied. Brent fell about 5.5%, yet Treasury yields did not fall. Constellation and NRG each rose after beating estimates.

MARKET PULSE

Stocks Bounced Back. Lenders and the Fed Have Not Yet Followed.

The S&P 500 rose about 2.4% on Monday, the Nasdaq about 2.7% and the Dow about 1,100 points. The VIX fell 22% to near 20. The rebound followed Wall Street's worst week in 19 months.

Chip stocks led, with Nvidia the main exception. Brent fell about 5.5% to near $93, yet the 10-year Treasury yield edged up to about 4.88%.

AI's most debt-dependent builders joined the rally. CoreWeave (CRWV) rose 5.6% and Nebius (NBIS) 9.2%. The cost of insuring CoreWeave's debt against default is up about 50% in a month, according to Deutsche Bank (DB) data.

Investor Signal

Credit markets have not yet shown that lenders came back with stock buyers. CoreWeave reports Tuesday after the close. Its funding plans will show whether lenders still back the AI buildout.

PREMIER FEATURE

Elon Musk's $2.1 Trillion Hit List

The SpaceX IPO made Elon Musk the wealthiest man who has ever lived.

Now he's spending it to complete his dynasty...

He's already acquired a $40 billion AI firm and a $1 billion turbine company.

But a handful of companies still stand between him and total control of the space economy.

Click here to see why early investors could walk away with a fortune.

CHIPS WATCH

AMD Rose 13%. Nvidia Fell 4% in Its First Session Since the Board Probe.

Nvidia (NVDA) fell 4.3% to $178.67 in its first regular session since its board opened an independent investigation tied to chief executive Jensen Huang.

Advanced Micro Devices (AMD) jumped 13.3% on a day Oppenheimer (OPY) upgraded it to Outperform. Marvell Technology (MRVL) gained 9.5% and Broadcom (AVGO) 8.8%. That left Nvidia about 9 points behind the VanEck Semiconductor ETF.

The board acted after press reports that Huang was the target of a foreign intelligence effort. It said it has no reason to believe national security or company secrets were compromised, and none of the reports' claims has been established. Polymarket's contract on Huang leaving by Dec. 31 ended near 15.5 cents, up about a point.

Investor Signal

The selling stayed with Nvidia while peers that sell to the same data-center customers rose. That points to a company-specific governance discount rather than a change in AI demand. The risk runs through Washington, where three House committee chairs asked Huang to answer their briefing request by Wednesday. Results on Nov. 17 come a day before the closed-door briefing the chairs requested. A gap that persists past both dates would suggest investors see a risk that a board review cannot close.

RATES WATCH

Brent Fell 5.5%. Two Fed Officials Still See Inflation Pressure.

Brent hit a two-month low even as the Iran talks went backwards. Secretary of State Marco Rubio said Sunday the talks were not close to a breakthrough.

The two-year Treasury yield rose about 4 basis points anyway. Chicago Fed President Austan Goolsbee and Richmond Fed President Tom Barkin pointed to costs that oil does not touch. Goolsbee also said the AI data-center buildout is starting to look like demand overheating.

Investor Signal

Despite cheaper crude, futures put December hike odds above 80%, and prediction markets near 80%. Both officials placed inflation in services and pass-through pricing, where lower oil helps only at the margin. October consumer prices arrive Tuesday morning without the usual yearly change, and forecasts center on a 0.3% monthly gain. A hot core reading would back Goolsbee's case and test buyers at the 10-year auction later that day.

FROM OUR PARTNERS

The REAL Reason Trump Is Invading Iran

For a moment…

Forget about Trump’s ties to Israel.

Forget about reports of Iran’s nuclear program.

Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.

Click here to find out what it is.

If you have even a single dollar invested in the U.S. stock market, this is going to directly impact you.

Discover the reason here.

POWER WATCH

Two Power Producers Rose 10%. Only One Raised Its Outlook.

Constellation Energy (CEG) rose 10.5% and NRG Energy (NRG) 10.4%. Both beat estimates by wide margins, and both sell power into the AI buildout.

Constellation beat by about $1.16 a share but lifted its full-year midpoint by only 65 cents. That gap suggests part of the upside was already built into the old range or will not repeat, and the release does not say which.

NRG kept its 2026 range and gave a first 2027 range whose $9.05 adjusted-earnings midpoint sits 15 cents above this year's. That range leaves out a $4 billion plant sale that still needs federal and New York approvals.

Investor Signal

Buyers rewarded the quarters even though neither company's outlook kept pace with its results. After last week's selloff over a Texas pledge to pause data-center approvals, Monday's gains suggest investors are still willing to pay for AI power demand. Constellation's implied fourth quarter will show whether the beat repeats. For NRG, regulatory approval of the plant sale is the next step that changes the math.

DEALS WATCH

In Two Deals, the Biggest Owner Takes Stock and Others Can Take Cash.

Surgery Partners (SGRY) closed at $26.45, above its new $25 cash deal price. Its special committee chose the raised offer, up from $23.50, from a Bon Secours Mercy Health affiliate over a non-binding $28 proposal. It cited a slower or less certain closing, regulatory risk and missing contract protections.

Bain Capital, which owns about 39%, rolls its shares and takes no cash. If stockholders approve and closing slips past March 1, 2027, other holders earn a ticking fee that can lift the price to as much as $26.61 a share.

Greenfire Resources (GFR) jumped 38% after Strathcona Resources agreed to buy it. Waterous Energy Fund, a private-equity investor, owns 57% of the buyer and 72% of Greenfire, and it will take Strathcona shares. Minority holders can elect C$11 in cash without proration.

Investor Signal

In both deals the biggest holder keeps equity, while cash terms anchor the price for everyone else. Surgery Partners closed less than 1% below its maximum, so traders appear to allow for a higher bid, though the price alone cannot show how much. Greenfire's deal needs a majority of minority votes at both companies, on top of two-thirds of all votes, so minority holders can block it.

PARTNER SPOTLIGHT

Elon Musk: This Could be 180 Times Bigger than SpaceX IPO

Elon Musk is on record predicting this new opportunity is set to be 180 times bigger than the SpaceX IPO.

That IPO minted 4,400 millionaires overnight.

If this is 180 times bigger…

Just imagine how many more Americans will become millionaires.

Will you be one of them? Click here now.

CRYPTO WATCH

Wall Street Built More Crypto Plumbing. Bitcoin Sat Out the Rally.

Coinbase (COIN) won final federal approval for a national trust bank for institutional custody. It carries no authority to take deposits or make loans. PNC (PNC) began a limited pilot that turns incoming USDC payments into dollars on arrival.

The New York Stock Exchange, owned by Intercontinental Exchange (ICE), chose Avalanche to settle a planned tokenized-stock venue, pending regulatory approval. Avalanche's token rose about 8%, the same day Charles Schwab (SCHW) added it for retail clients.

Bitcoin ended flat as stocks rallied. Strategy (MSTR) spent $188.3 million buying back preferred stock in the week through Sunday, 2.3 times its bitcoin purchases. Its shares fell 2.6%.

Investor Signal

Banks, exchanges and regulators are opening routes into crypto, while the largest corporate holder spent more last week on its own preferred stock than on coins. Strategy's average cost of $75,456 a coin sits just above bitcoin's price. It funds purchases by selling shares, and MSCI decides Wednesday whether Strategy stays in its indexes. A removal could make that money harder to raise.

CLOSING LENS

Monday showed investors separating one company from its industry. Chip buyers stayed with AI and stepped back from Nvidia while its board review runs. Oil fell, yet two Fed officials said the costs that matter now sit elsewhere.

Stock buyers moved first. Tuesday's consumer prices and CoreWeave's results will show whether lenders and the Fed follow.

Big Pharma’s new ‘AI co-scientist’

…is already at work inside Bristol Myers Squibb.

Free report here →